References of "9999"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLa manie et la mélancolie comme crises de l’identité narrative et de l’intentionnalité
Englebert, Jérôme ULg; Stanghellini, Giovanni

in Evolution Psychiatrique (in press)

Objectives: Our objective is to achieve a phenomenological cross-study of melancholic and manic crises. To do this, we analyze the relationship between these two psychopathological states by means of the ... [more ▼]

Objectives: Our objective is to achieve a phenomenological cross-study of melancholic and manic crises. To do this, we analyze the relationship between these two psychopathological states by means of the concepts of "narrative identity" and "intentionality". Method: From clinical cases and with reference to various theoretical models derived from phenomenological psychopathology, we discuss similarities and differences between mania and melancholia. Results: Narrative identity is based on a double movement: that of the enunciation of a speech focused on his history and that of an act of creation. From different clinical situations, we find that: (1) the melancholic retains the ability to elaborate a narrative about his history but the creative dimension of this narrative is absent, and (2) conversely, the manic experiences only the creative dimension. Discussion: Intentionality, as the tendency of consciousness to move toward something beyond itself, proves to be the center of the manic existence without being able to set itself within the boundaries of factual constraints. The melancholic, conversely, experiences an existence in which consciousness has lost its capacity to aim beyond itself. Conclusions: Melancholia and mania are quite specific forms of being-in-world with particular identity and temporal experiences. These two states share a fundamental psychopathological feature, that we named here “manque chiasmatique”: they are disorders of the intentional movement that constitutes narrative identity, that is, of the dialectics between the rootedness (“enracinenment”) of self in its past and the possibility of creation of a new identity. [less ▲]

Detailed reference viewed: 37 (0 ULg)
Peer Reviewed
See detailIntroduction: (Re)productive Traditions, Cultural Transmission and Egyptology
Gillen, Todd Jonathan ULg

in Gillen, Todd Jonathan (Ed.) (Re)productive Traditions in Ancient Egypt (in press)

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailEffect of storage and cooking on the fatty acid profile of omega-3 enriched eggs and pork meat marketed in Belgium
Douny, Caroline ULg; El Khoury, Rawad; Delmelle, Julien et al

in Food Science & Nutrition (in press)

Detailed reference viewed: 24 (4 ULg)
Full Text
Peer Reviewed
See detailChemical composition of colostrum from Azawak cow in Niger compared with meta-analytical data
Abdou, Harouna; Marichatou, Hamani; Beckers, Jean-François ULg et al

in Animal Genetic Resources Information = Bulletin d'Information sur les Ressources Génétiques Animales = Boletin de Informacion sobre Recursos Geneticos Animales (in press)

This study aimed at comparing data obtained from Azawak zebu colostrum with literature data. The comparison was performed by a meta-analytical approach. Colostrum samples were hand-collected after 5 h ... [more ▼]

This study aimed at comparing data obtained from Azawak zebu colostrum with literature data. The comparison was performed by a meta-analytical approach. Colostrum samples were hand-collected after 5 h from 7 Azawak cows at calving between August 27, to September 10, 2009 in the Sahel. For data from literature, twenty one (21) references were identified in the following analytical databases: PubMed, Science Direct, Google scholar, Collection from University of Liege. The references were selected according to the following two criteria: i) only studies reported on bovine colostrum were used irrespective of breeds, and ii) among the selected studies, those not providing complete information to allow meta-analytical calculation were excluded. Samples were analyzed for immunoglobulins (IgG, IgM, IgA), lactoferrin, and chemical composition (dry mater, protein, fat, lactose, ash, Ca, P, NA, K, Mg). The mean levels of IgG, IgM, dry matter, protein and fat for Azawak cows were lower (P ˂ 0.001) than those obtained in other breeds; however colostrum from the Azawak was higher in IgA but the difference was not significant. For lactose and ash, mean values for Azawak cows were higher (P ˂ 0.001) than those from the literature. Contents of Ca, P, Na and Mg in Azawak bovine colostrum were significantly higher (P ˂ 0.001) than the mean levels in form the literature data. In conclusion, the colostrum from Azawak cows appears to be lower in most immunoglobulins, in fat and in protein than the values reported in the literature, but higher in lactose and minerals. This could be an adaptation to sahelian contraints. [less ▲]

Detailed reference viewed: 34 (7 ULg)
Full Text
Peer Reviewed
See detailPaul Hymans, la Belgique et les affaires internationales (1914-1927). Un homme et un État dans la « hiérarchie »
Genin, Vincent ULg

in L’arbitre de l’Europe. Fixer, penser, contester les hiérarchies politiques en Europe (in press)

Detailed reference viewed: 31 (13 ULg)
Full Text
Peer Reviewed
See detailVirtual reality as a complementary therapy to sexual addiction treatment
Cismaru Inescu, Adina; Andrianne, Robert ULg; Triffaux, Jean-Marc ULg

in International Journal of Advanced Computer Science (in press), 3(7), 1-5

Detailed reference viewed: 103 (30 ULg)
See detailLes corps saints des catacombes de Rome aux Pays-Bas : acteurs, réseaux, flux
Delfosse, Annick ULg

in Duhamelle, Christophe; Bacciochi, Stéphane (Eds.) Les corps saints des catacombes dans l’espace de la catholicité à l’âge moderne (XVIIe-XIXe siècles) (in press)

Detailed reference viewed: 16 (3 ULg)
Full Text
See detailIdentité territoriale et schizophrénie
Englebert, Jérôme ULg

in Gauthier, Jean-Marie; Weber, Yves; Vermeylen, Françoise (Eds.) et al Le corps partagé (in press)

Detailed reference viewed: 18 (7 ULg)
Full Text
See detailPrise en compte de l’expérience non formelle et informelle : aperçu du contexte européen
Danse, Cédric ULg; Peters, Stéphanie ULg; Faulx, Daniel ULg

in Valorisation de l'expérience en Europe: un dispositif en construction? (in press)

Ce texte est un apreçu des structures et directives européennes visant à développer la Formation Tout au Long de la Vie (Lifelong Learning) au travers de la reconnaissance des acquis non formels et ... [more ▼]

Ce texte est un apreçu des structures et directives européennes visant à développer la Formation Tout au Long de la Vie (Lifelong Learning) au travers de la reconnaissance des acquis non formels et infomels. Nous disctuons également des logiques qui sous-tendent l'application d'une telle politique. [less ▲]

Detailed reference viewed: 114 (39 ULg)
Full Text
See detailValorisation et validation de l’expérience et des compétences : pratiques en Belgique francophone
Danse, Cédric ULg; Peters, Stéphanie ULg; Faulx, Daniel ULg

in Valorisation de l'expérience en Europe: un dispositif en construction? (in press)

La valorisation de l'expérience connaît un développement considérable, en particulier depuis les accords de Lisbonne concernant la Formation Tout au Long de la Vie (FTLV) dans les années 2000. Située au ... [more ▼]

La valorisation de l'expérience connaît un développement considérable, en particulier depuis les accords de Lisbonne concernant la Formation Tout au Long de la Vie (FTLV) dans les années 2000. Située au confluent de stratégies individuelle, organisationnelle, nationale et continuentale, la reconnaissance des apprentissages non formels et informels, dont les avancées diffèrent selon les états membres de l'UE, est au coeur des attentions. Pour mieux saisir le développement en Belgique francophone de la prise en compte de l'expérience des individus, le présent chapitre dresse le paysage des strucutures officielles permettant de valoriser voire valider les compétences acquises par les individus tout au long de leur vie. [less ▲]

Detailed reference viewed: 369 (66 ULg)
Full Text
Peer Reviewed
See detailLe "Gate fever" : cristallisation et fossilisation de l’univers carcéral
Englebert, Jérôme ULg

in Sami-Ali; Cady, Sylvie (Eds.) Temporalité et psychosomatique (in press)

Detailed reference viewed: 34 (3 ULg)
Full Text
Peer Reviewed
See detailA European survey on attitudes towards pain and end-of-life issues in locked-in syndrome
Demertzi, Athina ULg; Jox, Ralf J; Racine, Eric et al

in Brain Injury (in press)

Objectives: Patients with locked-in syndrome often self-report a higher quality of life than generally expected. This study reports third-person attitudes towards several salient issues on locked-in ... [more ▼]

Objectives: Patients with locked-in syndrome often self-report a higher quality of life than generally expected. This study reports third-person attitudes towards several salient issues on locked-in syndrome. Methods: Close-ended survey among conference attendees from 33 European countries. Analysis included chi-square tests and logistic regressions. Results: From the 3332 respondents (33% physicians, 18% other clinicians, 49% other professions; 47% religious), 90% agreed that patients with locked-in syndrome can feel pain. The majority (75%) disagreed with treatment withdrawal, but 56% did not wish to be kept alive if they imagined themselves in this condition (p50.001). Religious and southern Europeans opposed to treatment withdrawal more often than non-religious (p50.001) and participants from the North (p¼0.001). When the locked-in syndrome was compared to disorders of consciousness, more respondents endorsed that being in a chronic locked-in syndrome was worse than being in a vegetative state or minimally conscious state for patients (59%) than they thought for families (40%, p50.001). Conclusions: Personal characteristics mediate opinions about locked-in syndrome. The dissociation between personal preferences and general opinions underlie the difference in perspective in disability. Ethical responses to dilemmas involving patients with locked-in syndrome should consider the diverging ethical attitudes of stakeholders. [less ▲]

Detailed reference viewed: 116 (7 ULg)
Peer Reviewed
See detailOrganic Rankine Cycles including fluid selection
Lemort, Vincent ULg; Declaye, Sébastien ULg; Quoilin, Sylvain ULg

in Handbook of Clean Energy Systems (in press)

An Organic Rankine Cycle (ORC) is similar to a steam Rankine cycle, except that the working fluid is not water but an organic compound, such as a refrigerant or a hydrocarbon, characterized by a lower ... [more ▼]

An Organic Rankine Cycle (ORC) is similar to a steam Rankine cycle, except that the working fluid is not water but an organic compound, such as a refrigerant or a hydrocarbon, characterized by a lower ebullition temperature than that of water. Hence lower temperature heat sources can be exploited such as solar energy, geothermal energy and waste heat recovery from many different processes. During the design phase of an ORC system, the selection of the working fluid must be conducted in parallel with the selection and the sizing of the components (mainly the expansion machine, the pump and the heat exchangers) and with the definition of the cycle architecture. This approach allows taking into consideration all technical constraints. Relevant properties of working fluids that should be considered during their selection are listed. Major characteristics of available displacement and turbo-expander technologies are described. The impact of the pump performance on the overall performance is discussed and strategies to increase the available NPSH are proposed. Finally, improved cycle architectures are introduced. Major applications of ORC systems are described: geothermal power plants, biomass CHP plants, waste heat recovery in industry, waste heat recovery on internal combustion engines and solar power plants. All these applications differ by the nature of the heat source and heat sink, the integration of the ORC with these sources and sinks, and the range of installed capacities. These differences yield specific designs, which are described. Performance achieved by systems in operation or prototypes are presented. [less ▲]

Detailed reference viewed: 167 (27 ULg)
Full Text
Peer Reviewed
See detailEnjeux politiques et critiques d'une philosophie des normes
Caeymaex, Florence ULg; Pieron, Julien ULg

in Dissensus (in press), 6(printemps 2014),

Detailed reference viewed: 17 (0 ULg)
Full Text
Peer Reviewed
See detailSpazio scritto e spazio non scritto nelle dossografie mediche su papiro
Ricciardetto, Antonio ULg

in Spazio scritto e spazio non scritto nel libro papiraceo: esperienze a confronto (in press)

Detailed reference viewed: 18 (3 ULg)
Full Text
Peer Reviewed
See detailAllogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT
Basak, GW.; Wiktor-Jedrzejczak, W.; Labopin, M. et al

in American Journal of Transplantation (in press)

We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in ... [more ▼]

We conducted a questionnaire survey of the 565 European Society for Blood and Marrow Transplantation centers to analyze the outcome of allogeneic hematopoietic stem cell transplantation (alloSCT) in recipients of solid organ transplantation (SOT). We investigated 28 patients with malignant (N=22) or nonmalignant diseases (N=6), who underwent 31 alloSCT procedures: 12 after kidney, 13 after liver, and three after heart transplantation. The incidence of solid organ graft failure at 60 months after first alloSCT was 33% (95% confidence interval [CI], 16–51%) for all patients, 15% (95% CI, 2–40%) for liver recipients, and 50% (95% CI, 19–75%) for kidney recipients (p = 0.06). The relapse rate after alloSCT (22%) was low following transplantation for malignant disorders, despite advanced stages of malignancy. Overall survival at 60 months after first alloSCT was 40% (95% CI, 19–60%) for all patients, 51% (95% CI, 16–86%) for liver recipients, and 42% (95% CI, 14–70%) for kidney recipients (p = 0.39). In summary, we show that selected SOT recipients suffering from hematologic disorders may benefit from alloSCT and experience enhanced long-term survival without loss of organ function. [less ▲]

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailPractical management of Chronic Myeloid Leukemia in Belgium
Benghiat, FS.; Beguin, Yves ULg; Dessars, B. et al

in Belgian Journal of Hematology (in press)

Imatinib has drastically changed the outcome of patients with chronic myeloid leukemia (CML), with the majority of them showing a normal life span. Recently, the development of second and third generation ... [more ▼]

Imatinib has drastically changed the outcome of patients with chronic myeloid leukemia (CML), with the majority of them showing a normal life span. Recently, the development of second and third generation tyrosine kinase inhibitors (TKIs) and the possibility of treatment discontinuation made the management of these patients more challenging. In this review, practical management guidelines of CML are presented, adapted to the Belgian situation in 2014. In first line chronic phase patients, imatinib, nilotinib and dasatinib can be prescribed. While second generation TKIs give faster and deeper responses, their impact on long-term survival remain to be determined. The choice of the TKI depends on CML risk score, priority for a deep response to allow a treatment-free remission protocol, age, presence of comorbid conditions, side effect profile, drug interactions, compliance concerns and price. Monitoring the response has to be made according the 2013 ELN criteria, and is based on the bone-marrow cytogenetic response during the first months and on the blood molecular response. Molecular follow-up is sufficient in patients with a complete cytogenetic response. For patients who fail frontline therapy, nilotinib, dasatinib, bosutinib and ponatinib are an option depending of the type of intolerance or resistance. T315I patients are only sensitive to ponatinib, which has to be carefully handled due to cardiovascular toxicity. Advanced phase diseases are more difficult to handle, with treatments including allogeneic stem cell transplantation, which is also an option for patients failing at least two TKIs. The possibility of treatment-free remission and pregnancy are also discussed. [less ▲]

Detailed reference viewed: 52 (0 ULg)
Full Text
Peer Reviewed
See detailRituximab therapy for hairy cell leukemia : a retrospective study of 41 cases
Leclerc, Mathieu; Suarez, Felipe; Noël, Marie-Pierre et al

in Annals of Hematology (in press)

The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and ... [more ▼]

The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and new agents are needed to further improve treatment outcome. We retrospectively studied 41 HCL patients from 10 centers in France and Belgium, who received 49 treatment courses with the anti-CD20 monoclonal antibody rituximab. Most of the patients were treated at relapse (84 % of cases) and rituximab was combined to a PA in 41 % of cases. Overall, response rate is 90 % including 71 % complete hematologic responses (CHRs). Frontline treatment, combination therapy, and absolute neutrophil count were associated with response in multivariate analysis. Three-year relapse-free and overall survivals are 68 and 90 %, respectively. When combined to a PA, rituximab yields a 100 % response rate, even beyond frontline therapy. In contrast, response rate is only 82 % (59 % CHR) when rituximab is used alone. In this latter setting, relapse rate is 56 % and median time to relapse is 17.5 months. All eight patients who were treated two times with the antibody responded again to retreatment. We confirm the high efficacy of the combination rituximab + PA. However, when rituximab is used as monotherapy, response rate is lower and the high relapse rate is a concern. Prospective clinical trials are needed to confirm the superiority of the combination rituximab + PA over PA alone, both as frontline therapy and at relapse. [less ▲]

Detailed reference viewed: 9 (0 ULg)
Full Text
Peer Reviewed
See detailLe cas clinique du mois. Hémangiome épithélioïde, une tumeur osseuse rare.
Gérard, Valérie; TOMASELLA, Marco ULg; KURTH, William ULg et al

in Revue Médicale de Liège (in press)

A case of pathological hip fracture associated with an epithelioid hemangioma is reported. Epithelioid hemangioma is a benign tumor, rarely localized in a bone. When the tumor is found on the skeleton, it ... [more ▼]

A case of pathological hip fracture associated with an epithelioid hemangioma is reported. Epithelioid hemangioma is a benign tumor, rarely localized in a bone. When the tumor is found on the skeleton, it generally involves a long bone. X-ray does not permit the differenciation of epithelioid hemangioma from other,malignant, vascular tumors. Therefore,the diagnosis requires surgery. Although no consensus treatment guidelines exist, the curettage – filling is most often proposed. [less ▲]

Detailed reference viewed: 38 (1 ULg)